TECHNIQUES FOR ALLOCATION OF CONTROL CHANNELS
    11.
    发明申请
    TECHNIQUES FOR ALLOCATION OF CONTROL CHANNELS 审中-公开
    分配控制信道的技术

    公开(公告)号:WO2012021337A2

    公开(公告)日:2012-02-16

    申请号:PCT/US2011/046314

    申请日:2011-08-02

    Abstract: Techniques are described for setting the Physical Downlink Control Channel search spaces for component carriers. If any component carrier is de-activated, the Carrier Indicator Fields (CIF) of remaining activated component carriers can be set to consecutive values. The User Element can utilize its identifier to determine the starting point Control Channel Elements in each subframe. The locations of Control Channel Elements for a component carrier can be determined based on its CIF. Accordingly, search spaces for different component carriers can potentially be closely spaced but not overlap.

    Abstract translation: 描述了用于为分量载波设置物理下行链路控制信道搜索空间的技术。 如果任何分量载波被禁用,则剩余的激活分量载波的载波指示符字段(CIF)可被设置为连续值。 用户单元可以利用其标识符来确定每个子帧中的起始点控制信道单元。 分量载波的控制信道单元的位置可以根据其CIF来确定。 因此,不同分量载波的搜索空间可能会被紧密隔开但不会重叠。

    PREVENTION AND TREATMENT OF INFLAMMATION AND ORGAN INJURY AFTER ISCHEMIA/REPERFUSION USING MFG-E8
    13.
    发明申请
    PREVENTION AND TREATMENT OF INFLAMMATION AND ORGAN INJURY AFTER ISCHEMIA/REPERFUSION USING MFG-E8 审中-公开
    使用MFG-E8进行隔离/再灌注后预防和治疗炎症和器官损伤

    公开(公告)号:WO2009064448A1

    公开(公告)日:2009-05-22

    申请号:PCT/US2008/012761

    申请日:2008-11-13

    Inventor: WANG, Ping

    CPC classification number: A61K38/37 A61K38/1808 C07K14/485

    Abstract: Provided are methods for preventing and treating inflammation and organ injury after ischemia/reperfusion, and methods for treating lung injury, comprising administering a milk fat globule epidermal growth factor-factor VIII (MFG-E8) to a subject. Also provided are pharmaceutical compositions comprising MFG-E8 in dosage form for preventing and treating inflammation and organ injury after ischemia/reperfusion, and for treating lung injury, and methods of preparing a pharmaceutical composition for preventing and treating inflammation and organ injury after ischemia/reperfusion, and for treating lung injury, comprising formulating MFG-E8 in a pharmaceutical composition.

    Abstract translation: 提供了用于预防和治疗缺血/再灌注后的炎症和器官损伤的方法以及治疗肺损伤的方法,包括向受试者施用乳脂肪球表皮生长因子因子VIII(MFG-E8)。 还提供了包含用于预防和治疗缺血/再灌注后的炎症和器官损伤以及用于治疗肺损伤的剂型中的MFG-E8的药物组合物,以及制备用于预防和治疗缺血/再灌注后炎症和器官损伤的药物组合物的方法 ,并用于治疗肺损伤,包括在药物组合物中制备MFG-E8。

    MEDIA FOR CLOSTRIDIUM BACTERIUM AND PROCESSES FOR OBTAINING A CLOSTRIDIAL TOXIN
    16.
    发明申请
    MEDIA FOR CLOSTRIDIUM BACTERIUM AND PROCESSES FOR OBTAINING A CLOSTRIDIAL TOXIN 审中-公开
    胶原细菌培养基和获得闭孔毒素的方法

    公开(公告)号:WO2006096164A1

    公开(公告)日:2006-09-14

    申请号:PCT/US2005/007014

    申请日:2005-03-03

    Abstract: Animal product free (APF) media and processes for the culture and fermentation of botulinum toxin producing Clostridium botulinum bacteria. The botulinum toxin obtained can be used for formulating and compounding botulinum toxin pharmaceutical compositions. The APF media can contain significantly reduced levels of meat or dairy by­products and use non-animal based products instead of the animal-­derived products. Preferably, the APF media used are substantially free or free of animal derived products.

    Abstract translation: 不含动物产品(APF)的培养基和产生肉毒杆菌毒素的肉毒杆菌的培养和发酵过程。 获得的肉毒杆菌毒素可用于配制和配制肉毒杆菌毒素药物组合物。 APF培养基可以显着降低肉类或乳品副产品的含量,并使用非动物产品而不是动物衍生产品。 优选地,所用的APF介质基本上是游离的或没有动物衍生的产品。

Patent Agency Ranking